Despite mounting evidence that exercise programs can improve cancer outcomes, access to them remains limited.

A lab accident is said to have led to the death of a woman from pneumonic plague in the Irkutsk region of Siberia, leading to nearly 200 possible contacts being put under observation

Hatteras Venture Partners names ex-NCI director Ned Sharpless as MD and Andrew Witty as chairman, while raising a $100M second opportunities fund.

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

A personalized ctDNA assay demonstrated 100% specificity but limited sensitivity for detecting recurrence after liver transplantation in HCC and CCA.

Twenty-five years after the draft of the human genome sequence, genomics has revolutionized many areas of biology, the diagnosis of familial and early-onset diseases, and the development of targete...

The FDA approved lirafugratinib for adults with previously treated, advanced cholangiocarcinoma harboring an FGFR2 fusion or other rearrangement after the REFOCUS trial showed a 46% ORR.

This comprehensive report provides current data on cancer incidence, mortality, and survivorship and outlines how federal investments in cancer research are improving and saving lives.

This is "Rally For Medical Research - Current Version 9/11/26" by AACR Events on Vimeo, the home for high quality videos and the people who love them.

These findings provide the rationale for advancing this assay into large-scale prospective studies to determine its performance, clinical utility, and potential role within population-based screening ...

The proportion of U.S. women who have never been screened for cervical cancer increased at a “troubling” rate over the past couple decades, according to researchers.As recently as a few ye...

THURSDAY, Sept. 3, 2026 (HealthDay News) -- Alcohol-attributable cancer mortality has increased in the United States, with mortality rates higher in men and tho

This week, Bobbi Conner talks with MUSC's Dr. Gerard Silvestri about research indicating that many advanced lung cancer patients never receive treatment.

This prognostic study compares tissue-free circulating tumor DNA analysis to tissue-free assay with tumor-informed assay results for estimating recurrence in patients with triple negative breast cance...

UC San Diego researchers have found a

This narrative review examines how liquid biopsy, particularly circulating tumor DNA, can guide treatment decisions by helping clinicians monitor cancer progression, detect minimal residual cancer, an...

Summary:. During cancer evolution, derepressed repetitive elements (REs) can trigger innate immune responses via “viral mimicry,” imposing selective immune pressure on emerging tumor cells. We propose...

Abstract. Obesity is associated with increased risk of at least 13 adult cancer types and is the second most common cause of cancer (after tobacco) in many populations. Uncertainty about the extent to...

Neoadjuvant cisplatin-based chemotherapy is a standard therapy for muscle-invasive bladder cancer. The efficacy and safety of neoadjuvant and adjuvant (perioperative) enfortumab vedotin–pembrolizum...

Discovery opens the door for improved diagnoses and treatments.

Biomedical research is increasingly constrained by repetitive, fragmented workflows that slow discovery. We introduce Biomni, a general-purpose biomedical artificial intelligence agent that autonomous...

In the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial, Platten and colleagues report the long-term clinical and immunological follow-up outcomes of a vaccine targeting mutant ...

Betty Frasier has lived through four cancer diagnoses, but what she thinks of most is the relationships that have carried her through treatment.

We caught up with Raymond N. DuBois fresh from his presentation at The Cancer Prevention Research Conference…

YouTube video by TEDx Talks

May is National Cancer Research Month. Thanks to research, more than 18.6 million people in the U.S. are cancer survivors.

This link will take you to a page that’s not on LinkedIn

Study finds only some mutations believed to cause cancer actually do — and age provides a clue

The Parker Institute for Cancer Immunotherapy is accelerating cancer research and commercialization under new CEO Karen Knudsen. The Sean Parker-backed PCI has cancer vaccines in its targets.

In this issue of The Lancet, Topaz and colleagues1 report the first systematic evaluation of the authenticity of references. The authors initially identified 125 615 773 references from 2 471 758 pape...

Investigators constructed weighted methylation risk scores to pinpoint specific risk factors associated with early-onset CRC versus late-onset CRC.

An AI model developed by researchers at Rochester, Minn.-based Mayo Clinic detected pancreatic cancer on abdominal CT scans taken up to three years before clinical diagnosis, according to a study publ...

Multimodal machine learning reveals that tumour microenvironments can be decomposed into spatially organized multicellular ecosystems, termed spatial ecotypes, that can be accessed non-invasively via ...

This perspective summarizes the ways in which artificial intelligence has already impacted cancer detection, understanding, and intervention, then posits that generative models are a key technology fo...

Identification of genetic variants associated with the efficacy and side effects of GLP1 medications could underpin development of precision medicine approaches in the treatment of obesity.

Here the authors use CRISPR activation screens to identify metabolite-sensing receptors that affect lymphocyte targeting and infiltration of tumors and engineer CAR T and CAR NK cells with these recep...

Setidegrasib was associated with antitumor activity and a low incidence of treatment discontinuation due to adverse events in patients with previously treated advanced <i>KRAS</i> p.G12D-mutated NSCLC or pancreatic ductal adenocarcinoma. (Funded by Astellas Pharma; ClinicalTrials.gov number, NCT0538 …

UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block th...

Temple Health today announced the appointment of Robert A. Winn, MD, as the next Cancer Center Director for Fox Chase Cancer Center, marking a defining moment that will shape the future of one of the ...